Insider · CIK 0001178579
TANG KEVIN
Reports to the SEC for 22 companies · SAN DIEGO, CA
Transactions
50
Companies
22
Filings
7
CIK
0001178579
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-26 | BOLDBoundless Bio, Inc.P Purchase | +$22.9K |
| 2026-10-23 | BOLDBoundless Bio, Inc.P Purchase | +$14.8K |
| 2026-10-22 | BOLDBoundless Bio, Inc.P Purchase | +$13.9K |
| 2026-10-20 | BOLDBoundless Bio, Inc.P Purchase | +$521.4 |
| 2026-10-19 | BOLDBoundless Bio, Inc.P Purchase | +$29.9K |
| 2026-10-19 | BOLDBoundless Bio, Inc.P Purchase | +$42.6K |
| 2026-10-16 | BOLDBoundless Bio, Inc.P Purchase | +$277K |
| 2026-08-26 | BOLDBoundless Bio, Inc.S Sale | −$54.4K |
| 2026-07-21 | BOLDBoundless Bio, Inc.P Purchase | +$7,259 |
| 2026-07-20 | BOLDBoundless Bio, Inc.P Purchase | +$3,960.12 |
| 2026-07-17 | BOLDBoundless Bio, Inc.P Purchase | +$646.6 |
| 2026-07-17 | FULCFulcrum Therapeutics, Inc.P Purchase | +$179K |
| 2026-07-16 | BOLDBoundless Bio, Inc.P Purchase | +$45.1K |
| 2026-07-16 | FULCFulcrum Therapeutics, Inc.P Purchase | +$415K |
| 2026-07-15 | FULCFulcrum Therapeutics, Inc.P Purchase | +$382K |
| 2026-07-15 | BOLDBoundless Bio, Inc.P Purchase | +$3,904 |
| 2026-07-14 | FULCFulcrum Therapeutics, Inc.P Purchase | +$191K |
| 2026-07-14 | FULCFulcrum Therapeutics, Inc.P Purchase | +$272K |
| 2026-07-14 | BOLDBoundless Bio, Inc.P Purchase | +$107K |
| 2026-07-13 | BOLDBoundless Bio, Inc.P Purchase | +$117K |
| 2026-07-13 | FULCFulcrum Therapeutics, Inc.P Purchase | +$45.9K |
| 2026-07-10 | BOLDBoundless Bio, Inc.P Purchase | +$105K |
| 2026-07-09 | BOLDBoundless Bio, Inc.P Purchase | +$17.36 |
| 2026-07-08 | BOLDBoundless Bio, Inc.P Purchase | +$35.3K |
| 2026-07-07 | BOLDBoundless Bio, Inc.P Purchase | +$39.2K |
| 2026-07-06 | BOLDBoundless Bio, Inc.P Purchase | +$67.4K |
| 2026-07-02 | BOLDBoundless Bio, Inc.P Purchase | +$24.5K |
| 2026-07-01 | BOLDBoundless Bio, Inc.P Purchase | +$178K |
| 2026-06-30 | BOLDBoundless Bio, Inc.P Purchase | +$65.9K |
| 2026-06-30 | BOLDBoundless Bio, Inc.P Purchase | +$250 |
| 2026-06-29 | BOLDBoundless Bio, Inc.P Purchase | +$158K |
| 2026-06-29 | BOLDBoundless Bio, Inc.P Purchase | +$1,926.96 |
| 2026-06-26 | BOLDBoundless Bio, Inc.P Purchase | +$191K |
| 2026-06-26 | BOLDBoundless Bio, Inc.P Purchase | +$340.36 |
| 2026-06-25 | BOLDBoundless Bio, Inc.P Purchase | +$362K |
| 2026-06-25 | BOLDBoundless Bio, Inc.P Purchase | +$1,305.6 |
| 2026-06-02 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$3.15M |
| 2026-06-02 | AUPHAurinia Pharmaceuticals Inc. · Short Put Options (potential obligation to buy)J Other | +$16.5K |
| 2026-06-01 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$5.25M |
| 2026-06-01 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$1,518.66 |
| 2026-05-29 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$35.3K |
| 2026-05-29 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$4.02M |
| 2026-03-03 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$2.62M |
| 2026-03-02 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$1.2M |
| 2026-03-02 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$1.65M |
| 2026-02-27 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$4.17M |
| 2026-02-27 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$3.03M |
| 2026-02-27 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$23K |
| 2025-08-05 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$2.34M |
| 2025-08-04 | AUPHAurinia Pharmaceuticals Inc.P Purchase | +$1.13M |
Recent filings
- 4TANG KEVIN0001178579-26-000020SEC(opens sec.gov)
- 4TANG KEVIN0001178579-26-000019SEC(opens sec.gov)
- 4TANG KEVIN0001178579-26-000018SEC(opens sec.gov)
- 4TANG KEVIN0001178579-26-000017SEC(opens sec.gov)
- 4TANG KEVIN0001178579-26-000016SEC(opens sec.gov)
- 4TANG KEVIN0001178579-26-000015SEC(opens sec.gov)
- 4TANG KEVIN0001178579-26-000014SEC(opens sec.gov)
Companies
- ACLARA BIOSCIENCES INCDirector
- Aptevo Therapeutics Inc.Exit FilingAPVO
- ARADIGM CORP10% Owner
- Ardea Biosciences, Inc./DEDirector, 10% Owner
- Aurinia Pharmaceuticals Inc.Director, Chief Executive Officer, 10% OwnerAUPH
- Bio Green Med Solution, Inc.10% OwnerBGMS
- Boundless Bio, Inc.10% OwnerBOLD
- Fulcrum Therapeutics, Inc.10% OwnerFULC
- HERON THERAPEUTICS, INC. /DE/Former DirectorHRTX
- Jounce Therapeutics, Inc.Director, 10% Owner
- LA JOLLA PHARMACEUTICAL CODirector, 10% Owner
- Mirati Therapeutics, Inc.10% Owner
- Nano Dimension Ltd.10% OwnerNNDM
- NEOSE TECHNOLOGIES INC10% Owner
- Northstar Neuroscience, Inc.10% Owner
- Odonate Therapeutics, Inc.Director, Chief Executive Officer, 10% Owner
- PENWEST PHARMACEUTICALS CO10% Owner, Former Director
- Rain Oncology Inc.10% Owner
- Singular Genomics Systems, Inc.10% Owner
- SYNAGEVA BIOPHARMA CORPDirector
- TCR2 THERAPEUTICS INC.10% Owner
- Vanda Pharmaceuticals Inc.10% OwnerVNDA
Address
4747 EXECUTIVE DRIVE SUITE 210
SAN DIEGO, CA, 92121